These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 18209080)
1. Down-regulation of MHC II in mesenchymal stem cells at high IFN-gamma can be partly explained by cytoplasmic retention of CIITA. Tang KC; Trzaska KA; Smirnov SV; Kotenko SV; Schwander SK; Ellner JJ; Rameshwar P J Immunol; 2008 Feb; 180(3):1826-33. PubMed ID: 18209080 [TBL] [Abstract][Full Text] [Related]
2. MHC class II transactivator (CIITA) expression is upregulated in multiple myeloma cells by IFN-gamma. Zhao M; Flynt FL; Hong M; Chen H; Gilbert CA; Briley NT; Bolick SC; Wright KL; Piskurich JF Mol Immunol; 2007 Apr; 44(11):2923-32. PubMed ID: 17300840 [TBL] [Abstract][Full Text] [Related]
3. Expression of the MHC class II transactivator (CIITA) type IV promoter in B lymphocytes and regulation by IFN-gamma. Piskurich JF; Gilbert CA; Ashley BD; Zhao M; Chen H; Wu J; Bolick SC; Wright KL Mol Immunol; 2006 Feb; 43(6):519-28. PubMed ID: 15950283 [TBL] [Abstract][Full Text] [Related]
4. Regulation of MHC class II expression and antigen processing in murine and human mesenchymal stromal cells by IFN-gamma, TGF-beta, and cell density. Romieu-Mourez R; François M; Boivin MN; Stagg J; Galipeau J J Immunol; 2007 Aug; 179(3):1549-58. PubMed ID: 17641021 [TBL] [Abstract][Full Text] [Related]
5. Malignant glioma cells use MHC class II transactivator (CIITA) promoters III and IV to direct IFN-gamma-inducible CIITA expression and can function as nonprofessional antigen presenting cells in endocytic processing and CD4(+) T-cell activation. Soos JM; Krieger JI; Stüve O; King CL; Patarroyo JC; Aldape K; Wosik K; Slavin AJ; Nelson PA; Antel JP; Zamvil SS Glia; 2001 Dec; 36(3):391-405. PubMed ID: 11746775 [TBL] [Abstract][Full Text] [Related]
6. IFN-gamma regulation of class II transactivator promoter IV in macrophages and microglia: involvement of the suppressors of cytokine signaling-1 protein. O'Keefe GM; Nguyen VT; Ping Tang LL; Benveniste EN J Immunol; 2001 Feb; 166(4):2260-9. PubMed ID: 11160280 [TBL] [Abstract][Full Text] [Related]
8. IL-1 beta inhibits IFN-gamma-induced class II MHC expression by suppressing transcription of the class II transactivator gene. Rohn W; Tang LP; Dong Y; Benveniste EN J Immunol; 1999 Jan; 162(2):886-96. PubMed ID: 9916712 [TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase 1/mSin3A disrupts gamma interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formation. Zika E; Greer SF; Zhu XS; Ting JP Mol Cell Biol; 2003 May; 23(9):3091-102. PubMed ID: 12697811 [TBL] [Abstract][Full Text] [Related]
10. Collagen and major histocompatibility class II expression in mesenchymal cells from CIITA hypomorphic mice. Xu Y; McDonald J; Perloff E; Butticè G; Schreiber BM; Smith BD Mol Immunol; 2007 Mar; 44(7):1709-21. PubMed ID: 16982097 [TBL] [Abstract][Full Text] [Related]
11. Adenosine signaling inhibits CIITA-mediated MHC class II transactivation in lung fibroblast cells. Fang M; Xia J; Wu X; Kong H; Wang H; Xie W; Xu Y Eur J Immunol; 2013 Aug; 43(8):2162-73. PubMed ID: 23681904 [TBL] [Abstract][Full Text] [Related]
12. Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells. Radosevich M; Song Z; Gorga JC; Ksander B; Ono SJ Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3185-95. PubMed ID: 15326139 [TBL] [Abstract][Full Text] [Related]
13. Class II transactivator (CIITA) promoter methylation does not correlate with silencing of CIITA transcription in trophoblasts. Holtz R; Choi JC; Petroff MG; Piskurich JF; Murphy SP Biol Reprod; 2003 Sep; 69(3):915-24. PubMed ID: 12748124 [TBL] [Abstract][Full Text] [Related]
14. Interferon (IFN) beta acts downstream of IFN-gamma-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48-kD DNA-binding protein, ISGF3-gamma. Lu HT; Riley JL; Babcock GT; Huston M; Stark GR; Boss JM; Ransohoff RM J Exp Med; 1995 Nov; 182(5):1517-25. PubMed ID: 7595221 [TBL] [Abstract][Full Text] [Related]
15. Differential selectivity of CIITA promoter activation by IFN-gamma and IRF-1 in astrocytes and macrophages: CIITA promoter activation is not affected by TNF-alpha. Nikcevich KM; Piskurich JF; Hellendall RP; Wang Y; Ting JP J Neuroimmunol; 1999 Oct; 99(2):195-204. PubMed ID: 10505975 [TBL] [Abstract][Full Text] [Related]
16. Two distinct gamma interferon-inducible promoters of the major histocompatibility complex class II transactivator gene are differentially regulated by STAT1, interferon regulatory factor 1, and transforming growth factor beta. Piskurich JF; Linhoff MW; Wang Y; Ting JP Mol Cell Biol; 1999 Jan; 19(1):431-40. PubMed ID: 9858567 [TBL] [Abstract][Full Text] [Related]
17. Class II transactivator-mediated regulation of major histocompatibility complex class II antigen expression is important for hematopoietic progenitor cell suppression by chemokines and iron-binding proteins. Broxmeyer HE; Cooper S; Hangoc G; Chang CH Exp Hematol; 2006 Aug; 34(8):1078-84. PubMed ID: 16863914 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of IFN-gamma-induced class II transactivator expression by a 19-kDa lipoprotein from Mycobacterium tuberculosis: a potential mechanism for immune evasion. Pai RK; Convery M; Hamilton TA; Boom WH; Harding CV J Immunol; 2003 Jul; 171(1):175-84. PubMed ID: 12816996 [TBL] [Abstract][Full Text] [Related]
19. Interferon-gamma induces major histocompatibility class II transactivator (CIITA), which mediates collagen repression and major histocompatibility class II activation by human aortic smooth muscle cells. Butticè G; Miller J; Wang L; Smith BD Circ Res; 2006 Mar; 98(4):472-9. PubMed ID: 16439692 [TBL] [Abstract][Full Text] [Related]
20. The major histocompatibility complex class II transactivator is differentially regulated by interferon-gamma and transforming growth factor-beta in microglial cells. Pazmany T; Tomasi TB J Neuroimmunol; 2006 Mar; 172(1-2):18-26. PubMed ID: 16360884 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]